Discover our impact all over the world.

Numbers displayed on the map are a representation of the activity in each country. Once you use the filter selections below, you will have the opportunity to explore projects and faculty in each country.

Projects + Faculty = Activity Number



Projects 948
Countries 149
Faculty 446
Health Topics 146

Filter from the selections below

Clear All Filters

HVTN 703/HPTN 081: A phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection

This phase 2b trial will provide a test of concept for antibody-mediated prevention (AMP) for HIV.  HVTN 703/HPTN 081 is the first study to evaluate whether broadly neutralizing monoclonal antibodies are effective in reducing acquisition of HIV-1 infection among at-risk populations. Funding is provided by HIV Vaccine Trials Network.

Active Dates 
07/01/2016 to 07/31/2021